- Home
- BLND vs KURA Comparison
BLND vs KURA Comparison
Compare BLND & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLND | KURA |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 894.7M | 1.0B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLND | KURA |
|---|---|---|
| Price | $3.37 | $10.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | $4.80 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 4.3M | 1.9M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $167,532,000.00 | $104,029,000.00 |
| Revenue This Year | N/A | $138.16 |
| Revenue Next Year | $19.81 | $67.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 37.61 | N/A |
| 52 Week Low | $2.50 | $5.41 |
| 52 Week High | $5.41 | $12.49 |
Technical Indicators
Market Signals| Indicator | BLND | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 58.36 | 46.40 |
| Support Level | $3.10 | $10.80 |
| Resistance Level | $3.23 | $12.31 |
| Average True Range (ATR) | 0.15 | 0.68 |
| MACD | 0.04 | -0.09 |
| Stochastic Oscillator | 92.98 | 8.36 |
Price Performance
Historical ComparisonAbout BLND Blend Labs Inc.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.